Biodesix Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Biodesix Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7507
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Biodesix Inc (Biodesix) is a molecular diagnostics company which discovers, develops and commercializes multivariate protein and genomic diagnostic blood tests in oncology for patients and doctors to enable precision medicine. These tests are used for early detection of diseases, diagnosis accuracy, disease monitoring and also provide improved therapeutic guidance for cancer patients. Biodesix’s product portfolio includes GeneStrat, a gene panel of clinically actionable mutations for tumor profiling for patients with advanced lung cancer; and VeriStrat, a serum proteomic test for patients with non-small cell lung cancer. The company collaborates with leading researchers to develop companion diagnostics for use with therapeutic agents and work in partnership with biotechnology and pharmaceutical companies such as Aveo Oncology and Biognosys. Biodesix is headquartered in Boulder, Colorado, the US.

Biodesix Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Biodesix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Biodesix Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Biodesix Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Biodesix Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Biodesix Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Biodesix Inc, Medical Equipment, Deal Details 12
Venture Financing 12
Biodesix Raises USD5.3 Million in Venture Financing 12
Biodesix Increases Size of Series G Financing 13
Biodesix Raises USD1.5 Million in Venture Financing 14
Biodesix Raises USD13.2 Million in Venture Financing 15
Integrated Diagnostics Raises USD6 Million in Series C Financing 16
Integrated Diagnostics Raises USD6.1 Million in Venture Financing 17
Biodesix Raises USD5 Million in Venture Financing 18
Biodesix Raises USD6 Million in Venture Financing 19
Biodesix Raises USD22 Million in Series F Financing Round 20
Biodesix Raises USD11 Million in Extended Series E Financing 21
Biodesix Raises Additional USD15 Million In Series E Financing Round 22
Biodesix Raises Additional USD12 million in Series E Funding 23
Integrated Diagnostics Raises US$30 Million In Series B Financing 24
Biodesix Raises US$10.4 Million In Series E Financing Round 26
Biodesix Raises Up To US$20 Million In Venture Financing 27
Integrated Diagnostics Secures USD1.5 Million Funding from Interwest Partners 28
Biodesix Raises US$20.8 Million In Extended Series D Financing 29
Integrated Diagnostics Raises US$10 Million In Third Tranche Of Series A Financing 30
Partnerships 32
Caprion Enters into Licensing Agreement with Integrated Diagnostics for Xpresys Lung Test 32
Biodesix and Positive Biosciences Enter into Agreement 33
Biodesix Enters into Distribution Agreement with Progenetics 34
Biodesix Enters into Co-Development Agreement with Bioyong Technology 35
Biodesix Forms Partnership with Biognosys 36
Biodesix Enters into Co-Development Agreement with Inivata 37
Biodesix Enters Into Agreement With Bruker Daltonics For VeriStrat 38
Agilent Technologies Enters Into Co-Development Agreement With Integrated Diagnostics 39
Acquisition 40
Biodesix Acquires Integrated Diagnostics 40
Biodesix Inc – Key Competitors 41
Biodesix Inc – Key Employees 42
Biodesix Inc – Locations And Subsidiaries 43
Head Office 43
Other Locations & Subsidiaries 43
Recent Developments 44
Product News 44
May 15, 2018: Society for Advanced Bronchoscopy Meets May 20 to Address Hot Topics in Advanced Bronchoscopy 44
Dec 20, 2017: Data Published In AACR Journal Suggest Biodesix Test in Development May Identify Melanoma Patients Who Could Benefit from Checkpoint Inhibitors 45
Dec 05, 2017: Biodesix Leaders Share Commercial and Pipeline Updates at Annual qPCR and dPCR Congress 46
Oct 25, 2017: Biodesix To Present Data at SITC Annual Meeting 47
Mar 28, 2017: Biodesix Announces Data To Be Presented at AACR Annual Meeting 2017 48
Mar 20, 2017: Study Results from Biodesix’s Immunotherapy Test Will Be Presented by Dr. Jeffrey Weber 49
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50

List of Tables
Biodesix Inc, Medical Equipment, Key Facts 2
Biodesix Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Biodesix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Biodesix Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Biodesix Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Biodesix Inc, Deals By Market, 2012 to YTD 2018 9
Biodesix Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Biodesix Raises USD5.3 Million in Venture Financing 12
Biodesix Increases Size of Series G Financing 13
Biodesix Raises USD1.5 Million in Venture Financing 14
Biodesix Raises USD13.2 Million in Venture Financing 15
Integrated Diagnostics Raises USD6 Million in Series C Financing 16
Integrated Diagnostics Raises USD6.1 Million in Venture Financing 17
Biodesix Raises USD5 Million in Venture Financing 18
Biodesix Raises USD6 Million in Venture Financing 19
Biodesix Raises USD22 Million in Series F Financing Round 20
Biodesix Raises USD11 Million in Extended Series E Financing 21
Biodesix Raises Additional USD15 Million In Series E Financing Round 22
Biodesix Raises Additional USD12 million in Series E Funding 23
Integrated Diagnostics Raises US$30 Million In Series B Financing 24
Biodesix Raises US$10.4 Million In Series E Financing Round 26
Biodesix Raises Up To US$20 Million In Venture Financing 27
Integrated Diagnostics Secures USD1.5 Million Funding from Interwest Partners 28
Biodesix Raises US$20.8 Million In Extended Series D Financing 29
Integrated Diagnostics Raises US$10 Million In Third Tranche Of Series A Financing 30
Caprion Enters into Licensing Agreement with Integrated Diagnostics for Xpresys Lung Test 32
Biodesix and Positive Biosciences Enter into Agreement 33
Biodesix Enters into Distribution Agreement with Progenetics 34
Biodesix Enters into Co-Development Agreement with Bioyong Technology 35
Biodesix Forms Partnership with Biognosys 36
Biodesix Enters into Co-Development Agreement with Inivata 37
Biodesix Enters Into Agreement With Bruker Daltonics For VeriStrat 38
Agilent Technologies Enters Into Co-Development Agreement With Integrated Diagnostics 39
Biodesix Acquires Integrated Diagnostics 40
Biodesix Inc, Key Competitors 41
Biodesix Inc, Key Employees 42
Biodesix Inc, Subsidiaries 43

List of Figures
Biodesix Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Biodesix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Biodesix Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Biodesix Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Biodesix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Biodesix Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Biodesix Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Biodesix Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Biodesix Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • GCL-Poly Energy Holdings Ltd (3800):電力:M&Aディール及び事業提携情報
    Summary GCL-Poly Energy Holdings Limited (GCL) is a solar energy holding company. Through its subsidiaries, associates and joint ventures, the company produces polysilicon and supplies silicon wafer. It also provides integrated solar system solutions covering project development, design, procurement …
  • Skyworks Solutions, Inc.:企業の戦略・SWOT・財務情報
    Skyworks Solutions, Inc. - Strategy, SWOT and Corporate Finance Report Summary Skyworks Solutions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Ferndale Pharma Group Inc-製薬・医療分野:企業M&A・提携分析
    Summary Ferndale Pharma Group Inc (Ferndale Pharma), formerly Ferndale Laboratories Inc is a manufacturer and distributor of pharmaceutical products. The company provides surgical instruments, medical supplies, skin care products, topical therapeutic products, prescription, over the counter products …
  • Hutchinson Aerospace & Industry, Inc.:企業の戦略・SWOT・財務情報
    Hutchinson Aerospace & Industry, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hutchinson Aerospace & Industry, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Cardax Inc (CDXI):製薬・医療:M&Aディール及び事業提携情報
    Summary Cardax Inc (Cardax), formerly Cardax Pharmaceuticals Inc is a life science company that discovers and develops pharmaceutical and consumer health technologies. The company discovers and develops anti-inflammatory dietary supplements, small molecule therapies, medicinal products, and drug pro …
  • Royal Dutch Shell Plc (RDSA)-石油・ガス分野:企業M&A・提携分析
    Summary Royal Dutch Shell plc (Shell) is an integrated oil and gas company. The company explores for and produces oil and gas from conventional fields and sources such as tight rock, shale and coal formations. Its refining and petrochemical complexes across the world add value to its upstream produc …
  • Insys Therapeutics Inc (INSY):企業の財務・戦略的SWOT分析
    Insys Therapeutics Inc (INSY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Volkswagen AG (VOW3):企業の財務・戦略的SWOT分析
    Volkswagen AG (VOW3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Gexa Energy LP:企業の戦略的SWOT分析
    Gexa Energy LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Vestas Wind Systems AS (VWS):電力:M&Aディール及び事業提携情報
    Summary Vestas Wind Systems A/S (Vestas) is a renewable energy company that designs, manufactures, constructs, installs, and services wind turbines. The company partners with customers to monitor wind energy production and performance of the wind power plant throughout its lifetime. It offers soluti …
  • GEE Group Inc (JOB):企業の財務・戦略的SWOT分析
    Summary GEE Group Inc (GEE) is a provider of professional staffing and recruiting services. The company’s staffing services comprise temporary staffing services, professional placement services, and management services. It provides direct hire, contract, and contract-to-hire services in accounting, …
  • Tiger Brands Ltd (TBS):企業の財務・戦略的SWOT分析
    Tiger Brands Ltd (TBS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Chugach Electric Association, Inc.:企業の発電所・SWOT分析2018
    Chugach Electric Association, Inc. - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information o …
  • Trinity Industries Inc (TRN)-エネルギー分野:企業M&A・提携分析
    Summary Trinity Industries, Inc. (Trinity) is a diversified industrial company. It produces and supplies railcars and railcar parts, inland barges, aggregates and highway products. It also manufactures tank containers, steel parts and structural wind towers. It also offers services such as railcar f …
  • P. H. Glatfelter Company (GLT):企業の財務・戦略的SWOT分析
    P. H. Glatfelter Company (GLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Eurofins Scientific SE (ERF):製薬・医療:M&Aディール及び事業提携情報
    Summary Eurofins Scientific SE (Eurofins) is a life sciences company, which provides a range of analytical testing services to clients in various industries. The company offers food and feed testing, biopharma services, pharma discovery services, genomic pharma services, pharma early development, ph …
  • Tongaat Hulett Ltd:企業の戦略的SWOT分析
    Tongaat Hulett Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • ULURU Inc (ULUR)-医療機器分野:企業M&A・提携分析
    Summary ULURU Inc (ULURU) is a developer and commercializer of wound care and muco-adhesive film products. The company’s products include Altrazeal and OraDisc. Its Altrazeal is a transforming powder dressing with Nanoflex technology for the management of exuding wounds. ULURU’s OraDisc is a polymer …
  • Eloxx Pharmaceuticals Inc:企業のM&A・事業提携・投資動向
    Eloxx Pharmaceuticals Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Eloxx Pharmaceuticals Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • NTT DOCOMO Inc:企業の戦略・SWOT・財務分析
    NTT DOCOMO Inc - Strategy, SWOT and Corporate Finance Report Summary NTT DOCOMO Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆